Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.

Szczegóły
Comments

Tytuł :: Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
Autorzy :: Goldman JD; Divisions of Infectious Disease and Organ Transplant, Swedish Medical Center, Seattle, WA, United States. Electronic address: .
Diaz G; Divisions of Infectious Disease, Providence Regional Medical Center, Everett WA, United States.
Urba WJ; Divisions of Hematology and Medical Oncology, Providence Cancer Institute Franz Clinic, Portland, OR, United States.; Pokaż więcej
Źródło :: International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106174.
Typ publikacji :: Letter
Język :: English
Imprint Name(s) :: Original Publication: Amsterdam : Elsevier Science Publishers, c1991-
MeSH Terms :: Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
COVID-19/*drug therapy
Hydroxychloroquine/*therapeutic use
SARS-CoV-2/*pathogenicity
Anti-Bacterial Agents/therapeutic use ; Antimalarials/therapeutic use ; COVID-19/virology ; Clinical Trials as Topic ; Drug Combinations ; Drug Repositioning ; Humans ; Politics ; Uncertainty
References :: Cell Discov. 2020 Mar 18;6:16. (PMID: 32194981)
Substance Nomenclature :: 0 (Anti-Bacterial Agents)
0 (Antimalarials)
0 (Antiviral Agents)
0 (Drug Combinations)
4QWG6N8QKH (Hydroxychloroquine)
83905-01-5 (Azithromycin)
Entry Date(s) :: Date Created: 20210107 Date Completed: 20210114 Latest Revision: 20210227
Update Code :: 20210301
PubMed Central ID :: PMC7836516
DOI :: 10.1016/j.ijantimicag.2020.106174
PMID :: 33408020
: Opinia redakcyjna

Full Text Finder

Comment in: Int J Antimicrob Agents. 2021 Jan;57(1):106241. (PMID: 33408031)

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu